Skip to content
  • Sunday, 26 July 2026
  • 3:55 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • AMSBIO Reports Karolinska Institutet’s Groundbreaking Research Using AAV Products to Uncover Neural Basis of Rheumatoid Arthritis Pain
Biotech & Genetic Research

AMSBIO Reports Karolinska Institutet’s Groundbreaking Research Using AAV Products to Uncover Neural Basis of Rheumatoid Arthritis Pain

Jia Lissa May 14, 2026 0

AMSBIO, a leading provider of life science reagents and services, has announced its involvement in a pivotal research endeavor by…

Read More
Stem Cell & Regenerative Medicine

First Blueprint of Human Skeletal Development Reveals Origins of Arthritis and Bone Growth Disorders

Dwi Wanna May 12, 2026 0

In a landmark achievement for regenerative medicine and developmental biology, an international team of scientists has unveiled the first comprehensive…

Read More
Stem Cell & Regenerative Medicine

Human Skeletal Development Blueprint Reveals New Insights into Arthritis and Congenital Bone Conditions

Dwi Wanna May 5, 2026 0

In a landmark achievement for regenerative medicine and developmental biology, researchers have unveiled the first comprehensive "blueprint" of human skeletal…

Read More
Stem Cell & Regenerative Medicine

First Blueprint of Human Skeletal Development Reveals Cellular Origins of Arthritis and Congenital Bone Conditions

Dwi Wanna Mar 23, 2026 0

Researchers from the Wellcome Sanger Institute and their international collaborators have achieved a significant scientific milestone by mapping the first…

Read More

Posts pagination

1 2
Breakthrough in Ultrafast Imaging Captures Phase and Intensity Dynamics of Femtosecond Phenomena in Single ShotThe Secret Recipe for Life: Earth’s Early Oxygen Levels Were Crucial for HabitabilityNew Research Uncovers Brain Circuit That Transforms Acute Pain into Chronic SufferingUnveiling Earth’s Hidden Arteries: First Global Maps Reveal 110 Quadrillion Kilometers of Vital Fungal Networks
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ